Management of metastatic melanoma: improved survival in a national cohort following the approvals of checkpoint blockade immunotherapies and targeted therapies.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2018
published in
has subject area
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Immunological
- Comorbidity
- Disease Management
- Female
- Health Care Surveys
- Humans
- Immunotherapy
- Male
- Melanoma
- Middle Aged
- Molecular Targeted Therapy
- Neoplasm Staging
- Odds Ratio
- Protein Kinase Inhibitors
- Proto-Oncogene Proteins B-raf
- Registries
- Symptom Assessment
- United States
- Young Adult